Teleflex Incorporated (NYSE:TFX ) Q3 2024 Results Conference Call October 31, 2024 8:00 AM ET Company Participants Lawrence Keusch - Vice President-Investor Relations & Strategy Development Liam Kelly - Chairman, President & Chief Executive Officer Thomas Powell - Executive Vice President & Chief Financial Officer Conference Call Participants Patrick Wood - Morgan Stanley Matthew O'Brien - Piper Sandler Jayson Bedford - Raymond James Shagun Singh - RBC Matt Taylor - Jefferies Larry Biegelsen - Wells Fargo Anthony Petrone - Mizuho Group David Turkaly - Citizens JMP Craig Bijou - Bank of America Michael Polark - Wolfe Research Mike Matson - Needham Kristen Stewart - CL King Operator Good morning, ladies and gentlemen, and welcome to the Teleflex Third Quarter 2024 Earnings Conference Call. [Operator Instructions] Please note that this conference call is being recorded, and will be available on the company's website for replay shortly.
Although the revenue and EPS for Teleflex (TFX) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Teleflex (TFX) came out with quarterly earnings of $3.49 per share, beating the Zacks Consensus Estimate of $3.38 per share. This compares to earnings of $3.64 per share a year ago.
Surgical equipment maker Teleflex reported a better-than-expected profit for the third quarter on Thursday, helped by strong demand for its medical devices.
Teleflex launches the next-generation Arrow VPS Rhythm DLX Device and NaviCurve Stylet in Canada.
Teleflex (TFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Investors with an interest in Medical - Instruments stocks have likely encountered both Teleflex (TFX) and Edwards Lifesciences (EW). But which of these two companies is the best option for those looking for undervalued stocks?
Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Edwards Lifesciences (EW). But which of these two companies is the best option for those looking for undervalued stocks?
Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Edwards Lifesciences (EW). But which of these two stocks offers value investors a better bang for their buck right now?
TFX instils optimism with its robust performance in the Interventional category and potential in Asia.
Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Penumbra (PEN). But which of these two stocks offers value investors a better bang for their buck right now?
Teleflex (TFX) publishes an analysis of clinical data showcasing the Titan SGS Stapler's enhanced clinical outcomes and significant efficiency benefits.